Dr. Manjeet Kaur Achreja, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 614 N Broad St, Seagrove, NC 27341 Phone: 336-873-7248 Fax: 336-873-7238 |
News Archive
Natera (NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, and Biopticka Laborator, one of the largest and most well-established laboratories in the Czech Republic, today announced a Constellation™ technology transfer licensing agreement that enables Biopticka Laborator to leverage Natera's proprietary single nucleotide polymorphism-based (SNP) technology to screen for fetal aneuploidies.
Patients likely to benefit the most from antiviral therapy for influenza were prescribed these drugs infrequently during the 2012-2013 influenza season, while antibiotics may have been overprescribed.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.
The team found there were no additional side effects from using robot assisted surgery, and recovery from surgery was quicker in most cases.
› Verified 5 days ago